Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease

Yuki Fujii; Makoto Takei; Risa Hayashi; Ryuichiro Yagi; Megumi Kawano; Ayaka Endo; Kenji Suzuki; Naoki Hirata; Tasuku Hasegawa; Toshiyuki Takahashi

doi:10.1016/j.jaccao.2020.02.018

Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease

JACC CardioOncol. 2020 Jun 16;2(2):320-323. doi: 10.1016/j.jaccao.2020.02.018. eCollection 2020 Jun.

Authors

Affiliation

¹ Department of Cardiology, Saiseikai Central Hospital, Tokyo, Japan.

No abstract available

Keywords: BNP, brain natriuretic peptide; HOHF, high-output heart failure; IL, interleukin; MPD, myeloproliferative disease; PH, pulmonary hypertension; RHC, right heart catheterization; VEGF, vascular endothelial growth factor; heart failure; pharmacotherapy; pulmonary hypertension; treatment.

Publication types

Review